Lee JB, Khan DH, Hurren R, et al. Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234-245.

doi:10.1182/blood.2023019985

In the conflict-of-interest disclosure paragraph on page 244, the following disclosure for Li Zhang should have been included: holds stock in WYZE Biotech Co Ltd.

2023

Sign in via your Institution

Lee JB, Khan DH, Hurren R, et al. Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234-245.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Lee JB, Khan DH, Hurren R, et al. Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234-245.

This feature is available to Subscribers Only

My Account

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only